| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_228395c8d48f107e3f3b31a7c9356c10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_421f09e942d7eb3d781cfe550c616f06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b1534a36cd27b0fa39968dbd088cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1d0677dc5d441f0fc01f1cc20171b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521f30d53aed7b8ce93be31a573c323d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3294f9aa9a7a4a76aaacabc05d7364a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1112c894dc3c65899d91e34604401f5 |
| publicationDate |
2020-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200046618-A |
| titleOfInvention |
Recombinant protein for myocardial infarction treatment or prevention and composition for myocardial infarction treatment or prevention containing thereof |
| abstract |
The present invention is a recombinant protein for preventing or treating myocardial infarction based on the milk fat globule-EGF factor 8 (MFG-E8) protein, consisting of the amino acid sequence of SEQ ID NO: 1, and remodeling through fibrosis by myocardial infarction. It provides excellent anti-fibrotic effect to the heart tissue of the subject, thereby restoring heart size and heartbeat to normal levels. In addition, the present invention relates to a pharmaceutical composition comprising a recombinant protein for prevention or treatment of recombinant myocardial infarction based on the milk fat globule-EGF factor 8 (MFG-E8) protein to form the amino acid sequence of SEQ ID NO: 1 Do |
| priorityDate |
2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |